iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Bulimia Nervosa

Bulimia Nervosa

Assessment and management of bulimia nervosa.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Mental Health

Clinical Guidelines

NICE guideline [NG69]
National
NICE guideline [NG69]: Bulimia nervosa treatment for adults
National
NICE guideline [NG69]: Eating disorders: recognition and treatment
National
SIGN Guidelines for Eating Disorders
National
Bulimia nervosa and binge eating disorder - Haute Autorité de Santé
Local
Initial Evaluation, Diagnosis, and Treatment of Anorexia Nervosa and Bulimia Nervosa
Local
NICE guideline [NG69]: Eating disorders: recognition and treatment
Local
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Third Edition (2023)
Local

Recent iatroX Q&As

  • What are the key diagnostic criteria for bulimia nervosa according to the DSM-5?Updated: 8/16/2025
  • How should I approach the initial assessment of a patient suspected to have bulimia nervosa?Updated: 8/16/2025
  • What are the recommended first-line treatment options for bulimia nervosa in primary care?Updated: 8/16/2025
  • When should I consider referring a patient with bulimia nervosa to specialist mental health services?Updated: 8/16/2025
  • What are the potential medical complications of bulimia nervosa that I should monitor in my patients?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play